Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course-Reference-Cited by-同舟云学术

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course

Published:2018-09-27 Issue:10 Volume:5 Page:1211-1221
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Nourbakhsh Bardia¹,Bhargava Pavan¹^ORCID,Tremlett Helen²^ORCID,Hart Janace³,Graves Jennifer³,Waubant Emmanuelle³

Affiliation:

1. Department of Neurology; Johns Hopkins University; Baltimore Maryland

2. Faculty of Medicine (Neurology) and The Djavad Mowafaghian Centre for Brain Health; University of British Columbia; Vancouver British Columbia Canada

3. Department of Neurology; University of California San Francisco; San Francisco California

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acn3.637/fullpdf

Reference37 articles.

1. Epstein-Barr virus and multiple sclerosis;Lucas;J Neurol Neurosurg Psychiatr,2011

2. What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence;Weston;Neurodegener Dis Manag,2015

3. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection;Correale;Acta Neurol Scand,2015

4. Obesity and multiple sclerosis: a mendelian randomization study;Mokry;PLoS Med,2016

5. The epidemiology of multiple sclerosis: insights to a causal cascade;Goodin;Handb Clin Neurol,2016

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet;Immunological Reviews;2024-05-08

2. Decreased serum tryptophan levels in patients with MOGAD:a cross-sectional survey;Clinica Chimica Acta;2024-05

3. The role of the “gut microbiota-mitochondria” crosstalk in the pathogenesis of multiple sclerosis;Frontiers in Microbiology;2024-04-29

4. Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches;Pharmacology & Therapeutics;2024-04

5. Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation;Neurologic Clinics;2024-02